Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Senseonics Holdings (NY: SENS )

0.4255 +0.0073 (+1.75%)
Streaming Delayed Price Updated: 11:08 AM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Senseonics Holdings

< Previous 1 2 3 Next >
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Announces Business Updates
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
From Senseonics Holdings, Inc.
Via Business Wire
New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Announces UnitedHealthcare Coverage of Eversense® E3 CGM for Adults with Diabetes
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics to Participate in the Jefferies Healthcare Conference
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports First Quarter 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical Trial
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. and PHC Holdings Corporation To Host Joint Eversense CGM Virtual Analyst and Investor Event on March 15, 2023
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics to Present at the Stifel 2022 Healthcare Conference
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports Third Quarter 2022 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 8, 2022, at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.